Over the summer, 23andMe launched a collaborative study with Pfizer to study and research inflammatory bowel disease (IBD).

“We’ve been encouraged by the number of people diagnosed with either Crohn’s disease or ulcerative colitis who have joined the study.”
Read full article about the collaborative study here: http://bit.ly/1TA1FF9